• Home
  •  / LeMaitre Vascular

LeMaitre Vascular

OverviewSuggest Edit

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company develops, manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons. It offers brand name devices used in arteries and veins outside of the heart. 

TypePublic
Founded1983
HQBurlington, USMap
Websitelemaitre.com
Employee Ratings2.4More

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)479(+5%)
Revenue (FY, 2019)$117.2 M(+12%)
Share Price (Sept 2020)$32.5 (+2%)
Cybersecurity ratingBMore

Key People/Management at LeMaitre Vascular

George W. Lemaitre

George W. Lemaitre

Chairman and Chief Executive Officer
David B. Roberts

David B. Roberts

President, Board Director
Laurie A. Churchill

Laurie A. Churchill

Senior Vice President & General Counsel
Kimberly L. Cieslak

Kimberly L. Cieslak

Vice President, Marketing
Ryan H. Connelly

Ryan H. Connelly

Vice President, Research & Development
Andrew Hodgkinson

Andrew Hodgkinson

Senior Vice President, Clinical, Regulatory & Quality Affairs
Show more

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Melbourne, Vaughan, Shanghai and in 10 other locations
Burlington, US (HQ)
63 Second Ave
Melbourne, AU
36 Munster Terrace
Vaughan, CA
9135 Keele St, Suite B6
Shanghai, CN
Room 809, Shangguang Xuhui Center Jin, Block No.407 YiShan Road
Paris, FR
79 Avenue de Villiers
Sulzbach (Taunus), DE
Otto-Volger-Straße 3 - 5 a/b
Show all (14)

LeMaitre Vascular Financials and Metrics

LeMaitre Vascular Revenue

Embed Graph
View revenue for all periods
LeMaitre Vascular's revenue was reported to be $117.23 m in FY, 2019 which is a 11% increase from the previous period.
USD

Revenue (Q2, 2020)

24.9m

Gross profit (Q2, 2020)

17.0m

Gross profit margin (Q2, 2020), %

68.5%

Net income (Q2, 2020)

3.5m

EBIT (Q2, 2020)

4.9m

Market capitalization (22-Sept-2020)

657.4m

Closing stock price (22-Sept-2020)

32.5

Cash (30-Jun-2020)

20.0m

EV

681.7m
LeMaitre Vascular's current market capitalization is $657.4 m.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

100.9m105.6m117.2m

Revenue growth, %

5%11%

Cost of goods sold

30.2m31.6m37.4m

Gross profit

70.7m73.9m79.9m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

24.1m25.8m24.8m26.0m27.0m24.2m28.5m29.5m29.1m30.6m24.9m

Cost of goods sold

6.8m8.2m7.2m7.5m8.0m6.9m9.0m9.2m8.9m10.1m7.8m

Gross profit

17.4m17.5m17.6m18.5m19.0m17.3m19.5m20.3m20.2m20.5m17.0m

Gross profit Margin, %

72%68%71%71%70%71%68%69%69%67%69%
show all
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

19.1m26.3m11.8m

Accounts Receivable

15.0m15.7m16.6m

Prepaid Expenses

2.6m2.9m3.3m

Inventories

21.0m27.4m39.5m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

25.8m30.1m37.5m22.8m19.6m20.1m14.8m13.3m11.7m10.9m20.0m

Accounts Receivable

14.1m14.6m13.6m14.5m15.2m13.0m15.5m15.5m14.9m16.6m17.7m

Prepaid Expenses

2.0m2.9m3.5m2.3m2.5m4.3m3.1m2.1m3.2m1.9m2.8m

Inventories

20.6m20.5m21.1m21.8m21.7m23.9m29.4m32.2m36.7m40.6m
show all
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

17.2m22.9m17.9m

Depreciation and Amortization

4.1m4.3m5.4m

Inventories

(1.4m)(4.3m)(11.3m)

Accounts Payable

1.5m4.3m(596.0k)
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

3.2m7.9m12.9m3.9m12.6m16.9m3.5m8.1m13.3m3.2m6.7m

Depreciation and Amortization

979.0k2.0m3.0m1.0m2.1m3.1m1.3m2.6m4.0m1.5m3.2m

Inventories

(1.1m)(767.0k)(1.3m)(808.0k)(1.3m)(3.1m)(2.4m)(5.3m)(9.6m)(1.9m)

Accounts Payable

(367.0k)(550.0k)787.0k(2.1m)(82.0k)(345.0k)(3.5m)(4.1m)(2.0m)(3.3m)(2.1m)
show all
USDQ1, 2017

Financial Leverage

1.2 x
Show all financial metrics

LeMaitre Vascular Operating Metrics

FY, 2017FY, 2018FY, 2019

Facilities

13 22

Facilities Owned Internationally, square feet

6.14 k12.96 k

Product Lines

15 16 15

Sales Representatives

90 108 112
Show all operating metrics

LeMaitre Vascular Acquisitions / Subsidiaries

Company NameDateDeal Size
ArtegraftJune 22, 2020$90 m
CardioCelDecember 31, 2019
Tru-Incise (Eze-Sit) USDecember 31, 2019
VascuCelDecember 31, 2019
LeMaitre Cardial SASDecember 31, 2018
Syntel and PythonDecember 31, 2018
ProColDecember 31, 2016
RestoreFlowDecember 31, 2016
Restore Flow AllograftsNovember 10, 2016$14 m
Tru-Incise (Eze-Sit) OUSDecember 31, 2015
Show more

LeMaitre Vascular Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

Learn more about about our premium products
SecurityScorecard logo

LeMaitre Vascular Revenue Breakdown

Embed Graph

LeMaitre Vascular revenue breakdown by business segment: 51.0% from Lower Extremities, 31.0% from Carotid Artery and 18.0% from Other Areas

LeMaitre Vascular revenue breakdown by geographic segment: 53.9% from United States, 10.6% from Germany and 35.6% from Other Countries

LeMaitre Vascular Online and Social Media Presence

LeMaitre Vascular's Trends

Embed Graph

LeMaitre Vascular News and Updates

October 24, 2018

LeMaitre Vascular Acquires Cardial Business of BD

BURLINGTON, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the assets of Cardial, a subsidiary of BD (Becton, Dickinson & Company), located in Saint-Étienne, France. The total purchase price for the acquired assets was €2.0 …
September 26, 2018

LeMaitre Vascular Acquires Clot Management Business from Applied Medical

BURLINGTON, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it has acquired the vascular clot management business of Applied Medical Resources Corporation for $14.2 million, of which $11.0 million was paid at closing and $3.2 million will be pai…

LeMaitre Vascular Blogs

April 13, 2020

LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results

BURLINGTON, Mass. , April 13, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular , Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary, unaudited results and withdrew prior annual guidance for 2020 due to the potential impact of COVID-19.
February 18, 2020

LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020

LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 Content Import Tue, 02/18/2020 - 12:28 LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 February 18, 2020 at 1…
February 06, 2020

LeMaitre Vascular Announces Q4 2019 Financial Results

LeMaitre Vascular Announces Q4 2019 Financial Results Content Import Thu, 02/06/2020 - 16:06 LeMaitre Vascular Announces Q4 2019 Financial Results February 6, 2020 at 4:05 PM EST This release is a backfill from a News Wire Earnings BU…
January 17, 2020

Helen Goulding

Helen Goulding eileen.white@i… Fri, 01/17/2020 - 13:30 Helen Goulding Director, Northern Europe Helen Goulding has served as our Director, Northern Europe since October 2019. Ms. Goulding joined us in 2006 and has held the positions of UK Sales Representative, UK …
January 03, 2020

LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020

BURLINGTON, Mass. , Jan. 03, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 22 nd Annual Needham Growth Conference on Wednesday, January 15, 2020 at the Lotte New York Palace Hotel in New York City .
October 23, 2019

LeMaitre Vascular Announces Q3 2019 Financial Results

BURLINGTON, Mass. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular , Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2019 results, provided guidance, and announced an $0.085 /share dividend. Q3 2019 Results Sales of $29.1mm, +20% (+13% organic) vs.
Show more

 LeMaitre Vascular Frequently Asked Questions

  • When was LeMaitre Vascular founded?

    LeMaitre Vascular was founded in 1983.

  • Who are LeMaitre Vascular key executives?

    LeMaitre Vascular's key executives are George W. Lemaitre, David B. Roberts and Laurie A. Churchill.

  • How many employees does LeMaitre Vascular have?

    LeMaitre Vascular has 479 employees.

  • What is LeMaitre Vascular revenue?

    Latest LeMaitre Vascular annual revenue is $117.2 m.

  • What is LeMaitre Vascular revenue per employee?

    Latest LeMaitre Vascular revenue per employee is $244.7 k.

  • Who are LeMaitre Vascular competitors?

    Competitors of LeMaitre Vascular include Intact Vascular, Inari Medical and Synaptive Medical.

  • Where is LeMaitre Vascular headquarters?

    LeMaitre Vascular headquarters is located at 63 Second Ave, Burlington.

  • Where are LeMaitre Vascular offices?

    LeMaitre Vascular has offices in Burlington, Melbourne, Vaughan, Shanghai and in 10 other locations.

  • How many offices does LeMaitre Vascular have?

    LeMaitre Vascular has 14 offices.